| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Pathology Laboratory, Michigan Cancer Foundation, Detroit, Michigan 48201
The susceptibility of the rat mammary gland to carcinogenesis decreases with aging and is nullified by pregnancy and lactation. This work was carried out to determine whether these differences in susceptibility to carcinogenesis are the result of variations in cell kinetics induced by both aging and parity. Cell cycle (Tc) and growth fraction (GF) were studied in the mammary gland epithelium of young virgin, old virgin, and parous Sprague-Dawley rats. For the study of Tc, five young virgin, five old virgin, and five parous rats received while in estrus an i.p. injection of 1.7 µCi [3H]thymidine per g body weight. Mammary gland biopsies were taken at 2-hr intervals for the first 24 hr and every 4 hr thereafter up to 72 hr. GF was determined in two young virgin, two old virgin, and two parous rats in which an osmotic minipump releasing 1 µCi [3H]thymidine per hr was implanted i.p. After 5 days, the animals were killed, and the mammary glands were removed. Mammary gland biopsies and whole glands were fixed in Bouin's fluid and embedded in paraffin. Deparaffinized sections were processed for autoradiography. The labeled mitosis wave, labeling index, and GF were determined. The results indicated that, in young virgin rats, mammary gland Tc was 9.9 hr in the most undifferentiated structures (terminal end buds), lengthening to 17.3 hr in terminal ducts (TD) and to 28.2 hr in alveolar buds (AB). In the mammary gland of old virgin rats, Tc was 18.75 hr in terminal ducts in regression, 20.57 hr in TD, and 30.75 hr in AB. In parous rats, mammary gland Tc was 23.92 hr in TD and 49.63 hr in AB. Lengthening of Tc in all of these structures was due to a lengthening of G1, while the duration of the other phases of the cell cycle remained unchanged. GF was 0.55 in terminal end buds of young virgin rats, decreasing to 0.39 and 0.13 in TD and AB, respectively. In terminal ducts in regression of old virgin rats, GF was 0.19, decreasing to 0.054 and 0.030 in TD and AB, respectively. In TD and AB of parous rat, mammary gland GF was 0.009 and 0.004, respectively. These results suggest that the high susceptibility to carcinogenesis that has been demonstrated in young virgin rats is due to the presence of a large proliferative compartment, mainly in terminal end buds and TD, while the low susceptibility of parous animals is due to the formation of a large compartment of nonproliferating cells, and that those cells still proliferating have a longer G1 than do those of young and old virgin rats.
1 Supported by an institutional grant from the United Foundation of Greater Detroit and by USPHS Grant CA-23539 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Experimental Pathology Laboratory, Department of Biology, Michigan Cancer Foundation, 110 East Warren Ave., Detroit, Mich. 48201.
Received 8/27/79. Accepted 4/25/80.
This article has been cited by other articles:
|
|
 |
|
  M. Medvedovic, R. Gear, J. M. Freudenberg, J. Schneider, R. Bornschein, M. Yan, M. J. Mistry, H. Hendrix, S. Karyala, D. Halbleib, et al. Influence of fatty acid diets on gene expression in rat mammary epithelial cells Physiol Genomics, June 10, 2009; 38(1): 80 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moral, R. Wang, I. H Russo, C. A Lamartiniere, J. Pereira, and J. Russo Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature J. Endocrinol., January 1, 2008; 196(1): 101 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Britt, A. Ashworth, and M. Smalley Pregnancy and the risk of breast cancer Endocr. Relat. Cancer, December 1, 2007; 14(4): 907 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dave, R. R. Eason, S.R. Till, Y. Geng, M. C. Velarde, T. M. Badger, and R. C.M. Simmen The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN Carcinogenesis, October 1, 2005; 26(10): 1793 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Eason, M. C. Velarde, L. Chatman Jr, S. R. Till, Y. Geng, M. Ferguson, T. M. Badger, and R. C. M. Simmen Dietary Exposure to Whey Proteins Alters Rat Mammary Gland Proliferation, Apoptosis, and Gene Expression during Postnatal Development J. Nutr., December 1, 2004; 134(12): 3370 - 3377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Shan, M. Yu, H. A.J. Schut, and E. G. Snyderwine Susceptibility of Rats to Mammary Gland Carcinogenesis by the Food-Derived Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP) Varies with Age and Is Associated with the Induction of Differential Gene Expression Am. J. Pathol., July 1, 2004; 165(1): 191 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Goepfert, Y. E. Adigun, L. Zhong, J. Gay, D. Medina, and W. R. Brinkley Centrosome Amplification and Overexpression of Aurora A Are Early Events in Rat Mammary Carcinogenesis Cancer Res., July 15, 2002; 62(14): 4115 - 4122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Bonnette and D. L. Hadsell Targeted Disruption of the IGF-I Receptor Gene Decreases Cellular Proliferation in Mammary Terminal End Buds Endocrinology, November 1, 2001; 142(11): 4937 - 4945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rajkumar, R. C. Guzman, J. Yang, G. Thordarson, F. Talamantes, and S. Nandi Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis PNAS, September 25, 2001; 98(20): 11755 - 11759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Huynh, C. Y. Ng, C. K. Ong, K. B. Lim, and T. W. M. Chan Cloning and Characterization of a Novel Pregnancy-Induced Growth Inhibitor in Mammary Gland Endocrinology, August 1, 2001; 142(8): 3607 - 3615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Russo, Y.-F. Hu, X. Yang, and I. H. Russo Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 17 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Melbye, J. Wohlfahrt, U. Lei, B. N. Pedersen, H. T. Mouridsen, M. Lambe, and K. B. Michels {alpha}-Fetoprotein Levels in Maternal Serum During Pregnancy and Maternal Breast Cancer Incidence J Natl Cancer Inst, June 21, 2000; 92(12): 1001 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kuperwasser, J. Pinkas, G. D. Hurlbut, S. P. Naber, and D. J. Jerry Cytoplasmic Sequestration and Functional Repression of p53 in the Mammary Epithelium Is Reversed by Hormonal Treatment Cancer Res., May 1, 2000; 60(10): 2723 - 2729. [Abstract] [Full Text]
|
|
|
|
|
|
A. Shilkaitis, A. Green, V. Steele, R. Lubet, G. Kelloff, and K. Christov Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death Carcinogenesis, February 1, 2000; 21(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Green, A. Shilkaitis, and K. Christov 4-(Hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland Carcinogenesis, August 1, 1999; 20(8): 1535 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea PNAS, February 17, 1998; 95(4): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Niranjan, L Buluwela, J Yant, N Perusinghe, A Atherton, D Phippard, T Dale, B Gusterson, and T Kamalati HGF/SF: a potent cytokine for mammary growth, morphogenesis and development Development, January 9, 1995; 121(9): 2897 - 2908. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Russo Basis of Cellular Autonomy in the Subsceptibility to Carcinogenesis Toxicol Pathol, February 1, 1983; 11(2): 149 - 166. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
